Executive Director
Ronald G. Lafrenière, Ph.D.

Dr. Ron Lafrenière is the Executive Director of the Centre of Excellence in Neuromics of Université de Montréal where he supervises the scientific and administrative activities of the Centre. Before joining the CENUM, Dr. Lafrenière held the positions of General Director and Scientific Director of Emerillon Therapeutics Inc., a small biotech company located in Montréal. Dr. Lafrenière received his Ph.D. in Biology in 1997 under the supervision of Dr. Guy A. Rouleau. He completed a postdoctoral fellow at BioChem Pharma Inc. where he was subsequently promoted to a research position.

Dr. Lafrenière worked for Xenon Genetics Research Inc. from 2001 to 2003 before continuing his career at Emerillon Therapeutics. Dr. Lafrenière received an Industrial R&D Fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC) and was awarded the Prix d'excellence de l'Académie des grands Montréalais in 1998. He has written more than 35 publications in peer-reviewed journals.  Dr. Lafrenière has many years of experience in directing multidisciplinary research teams, developing research projects and carrying out administrative management, technology transfer and intellectual property management.

CONTACT

CHUM Research Centre
2,099 Alexandre-de-Seve Street
Room Y-3633
Montreal, Quebec H2L 2W5

Phone : 514-890-8000 ext. 24753
Fax : 514-412-7602
E-mail : ron.lafreniere@crchum.qc.ca

SELECTED PUBLICATIONS

Shink E, Harvey M, Tremblay M, Gagné B, Belleau P, Raymond C, Labbé M, Dubé MP, Lafrenière RG, Barden N. Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region. Am J Med Genet B Neuropsychiatr Genet. 2005 May 5;135(1):50-8.

Lafreniere RG, MacDonald ML, Dube MP, MacFarlane J, O'Driscoll M, Brais B, Meilleur S, Brinkman RR, Dadivas O, Pape T, Platon C, Radomski C, Risler J, Thompson J, Guerra-Escobio AM, Davar G, Breakefield XO, Pimstone SN, Green R, Pryse-Phillips W, Goldberg YP, Younghusband HB, Hayden MR, Sherrington R, Rouleau GA, Samuels ME. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet. 2004 May;74(5):1064-73. Epub 2004 Apr 1.

Lafrenière RG, Rochefort DL, Chrétien N, Rommens JM, Cochius JI, Kälviäinen R, Nousiainen U, Patry G, Farrell K, Söderfeldt B, Federico A, Hale BR, Cossio OH, Sørensen T, Pouliot MA, Kmiec T, Uldall P, Janszky J, Pranzatelli MR, Andermann F, Andermann E, Rouleau GA. Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet. 1997 Mar;15(3):298-302.

 Top